Ben R. Taylor

Insider Reports History

Location
44 Wall Street, 12 Th Floor, New York, NY
Signature
/s/ Kyle Nelson, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ben R. Taylor:

Stock Role Class Num Shares Value Price $ Report Date Ownership
RECURSION PHARMACEUTICALS, INC. Chief Financial Officer Class A Common Stock 790K $3.18M $4.03 Nov 25, 2025 Direct
RECURSION PHARMACEUTICALS, INC. Chief Financial Officer Stock Option (Right to Buy) 290K Jun 16, 2025 Direct

Insider Reports Filed by Ben R. Taylor

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RXRX RECURSION PHARMACEUTICALS, INC. Nov 25, 2025 1 -$9.15K 4 Nov 26, 2025 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Nov 17, 2025 1 -$49.3K 4 Nov 19, 2025 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Sep 15, 2025 1 -$34.1K 4 Sep 17, 2025 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Aug 15, 2025 1 -$67.2K 4 Aug 19, 2025 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Jun 16, 2025 1 -$34.7K 4 Jun 18, 2025 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. May 15, 2025 1 -$50.6K 4 May 19, 2025 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Apr 1, 2025 1 -$135K 4 Apr 3, 2025 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Mar 17, 2025 1 -$48.3K 4 Mar 19, 2025 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Feb 18, 2025 1 -$116K 4 Feb 20, 2025 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Feb 3, 2025 4 -$47.4K 4 Feb 5, 2025 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Dec 19, 2024 2 $0 4 Dec 20, 2024 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Dec 16, 2024 2 -$144K 4 Dec 18, 2024 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Nov 20, 2024 0 $0 3 Dec 2, 2024 Chief Financial Officer